Related references
Note: Only part of the references are listed.The Role of miRNA in Ovarian Cancer: an Overview
Lihui Zhao et al.
REPRODUCTIVE SCIENCES (2022)
Tankyrase inhibitors: emerging and promising therapeutics for cancer treatment
Anu Verma et al.
MEDICINAL CHEMISTRY RESEARCH (2021)
Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells
Usama A. Fahmy et al.
PHARMACEUTICS (2021)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
Maintenance olaparib for patients with newly diagnosed advanced ovarian cancer and a BRCA mutation (SOLO1/GOG 3004): 5-year follow-up of a randomised, double-blind, placebo-controlled, phase 3 trial
Susana Banerjee et al.
LANCET ONCOLOGY (2021)
Ovarian Cancer, Version 2.2020
Deborah K. Armstrong et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)
LINC00242/miR-1-3p/G6PD axis regulates Warburg effect and affects gastric cancer proliferation and apoptosis
Peng Deng et al.
MOLECULAR MEDICINE (2021)
Natural products in drug discovery: advances and opportunities
Atanas G. Atanasov et al.
NATURE REVIEWS DRUG DISCOVERY (2021)
Green Synthesis of Silver Nanoparticles Using Annona muricata Extract as an Inducer of Apoptosis in Cancer Cells and Inhibitor for NLRP3 Inflammasome via Enhanced Autophagy
Majid S. Jabir et al.
NANOMATERIALS (2021)
Icariin regulates miR-23a-3p-mediated osteogenic differentiation of BMSCs via BMP-2/Smad5/Runx2 and WNT/β-catenin pathways in osteonecrosis of the femoral head
Xiao-yun Zhang et al.
SAUDI PHARMACEUTICAL JOURNAL (2021)
Influence of icariin on inflammation, apoptosis, invasion, and tumor immunity in cervical cancer by reducing the TLR4/MyD88/NF-κB and Wnt/β-catenin pathways
Chunyang Li et al.
CANCER CELL INTERNATIONAL (2021)
First-in-Human Study of PF-06647020 (Cofetuzumab Pelidotin), an Antibody-Drug Conjugate Targeting Protein Tyrosine Kinase 7, in Advanced Solid Tumors
Michael L. Maitland et al.
CLINICAL CANCER RESEARCH (2021)
Icariin inhibits oral squamous cell carcinoma cell proliferation and induces apoptosis via inhibiting the NF-κB and PI3K/AKT pathways
Ling Sun et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2021)
Natural Products in Cancer Therapy: Past, Present and Future
Min Huang et al.
NATURAL PRODUCTS AND BIOPROSPECTING (2021)
miRDB: an online database for prediction of functional microRNA targets
Yuhao Chen et al.
NUCLEIC ACIDS RESEARCH (2020)
Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Wnt signaling in cancer: therapeutic targeting of Wnt signaling beyond β-catenin and the destruction complex
Youn-Sang Jung et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
Final survival analysis of NSGO-AVANOVA2/ENGOT-OV24: Combination of niraparib and bevacizumab versus niraparib alone as treatment of recurrent platinum-sensitive ovarian cancer—A randomized controlled chemotherapy-free study.
Mansoor Raza Mirza et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial
Jacobus Pfisterer et al.
LANCET ONCOLOGY (2020)
miR-454 suppresses the proliferation and invasion of ovarian cancer by targeting E2F6
Yunhe An et al.
CANCER CELL INTERNATIONAL (2020)
Targeting β-Catenin Signaling by Natural Products for Cancer Prevention and Therapy
Wen-Kai Yu et al.
FRONTIERS IN PHARMACOLOGY (2020)
Targeting miRNAs by natural products: A new way for cancer therapy
Beilei Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
Icariin-induced inhibition of SIRT6/NF-κB triggers redox mediated apoptosis and enhances anti-tumor immunity in triple-negative breast cancer
Linjiang Song et al.
CANCER SCIENCE (2020)
Casein Kinase 1α as a Regulator of Wnt-Driven Cancer
Chen Shen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
miR-1: A comprehensive review of its role in normal development and diverse disorders
Amin Safa et al.
BIOMEDICINE & PHARMACOTHERAPY (2020)
The epigenetic regulator Mll1 is required for Wnt-driven intestinal tumorigenesis and cancer stemness
Johanna Grinat et al.
NATURE COMMUNICATIONS (2020)
Inhibition of the Wnt/beta-catenin pathway enhances antitumor immunity in ovarian cancer
David W. Doo et al.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY (2020)
Regulation of microRNA function in animals
Luca F. R. Gebert et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2019)
MiR-542-3p, a microRNA targeting CDK14, suppresses cell proliferation, invasiveness, and tumorigenesis of epithelial ovarian cancer
Jingwei Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
The role of R-spondin 1 through activating Wnt/β-catenin in the growth, survival and migration of ovarian cancer cells
Qiong Liu et al.
GENE (2019)
Icariin suppresses cell cycle transition and cell migration in ovarian cancer cells
Pengzhen Wang et al.
ONCOLOGY REPORTS (2019)
Tankyrase Promotes Aerobic Glycolysis and Proliferation of Ovarian Cancer through Activation of Wnt/-Catenin Signaling
Hong-Yi Yang et al.
BIOMED RESEARCH INTERNATIONAL (2019)
Efficacy and Safety of Avelumab for Patients With Recurrent or Refractory Ovarian Cancer Phase 1b Results From the JAVELIN Solid Tumor Trial
Mary L. Disis et al.
JAMA ONCOLOGY (2019)
MiR-1-3p Inhibits Lung Adenocarcinoma Cell Tumorigenesis via Targeting Protein Regulator of Cytokinesis 1
Tao Li et al.
FRONTIERS IN ONCOLOGY (2019)
MicroRNA in Ovarian Cancer: Biology, Pathogenesis, and Therapeutic Opportunities
San-Nung Chen et al.
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2019)
A positive feedback loop of β-catenin/CCR2 axis promotes regorafenib resistance in colorectal cancer
Baochi Ou et al.
CELL DEATH & DISEASE (2019)
被撤回的出版物: Icariin inhibits cell proliferation, migration and invasion by down-regulation of microRNA-625-3p in thyroid cancer cells (Retracted article. See vol. 150, 2022)
Lei Fang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Icariin induces apoptosis of human lung adenocarcinoma cells by activating the mitochondrial apoptotic pathway
Xiaoli Wu et al.
LIFE SCIENCES (2019)
Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis
Vu Hong Loan Nguyen et al.
JOURNAL OF OVARIAN RESEARCH (2019)
Prediction of functional microRNA targets by integrative modeling of microRNA binding and target expression data
Weijun Liu et al.
GENOME BIOLOGY (2019)
Inhibitor of growth 3 induces cell death by regulating cell proliferation, apoptosis and cell cycle arrest by blocking the PI3K/AKT pathway
Song Zhao et al.
CANCER GENE THERAPY (2018)
miR-590-3p Promotes Ovarian Cancer Growth and Metastasis via a Novel FOXA2-Versican Pathway
Mohamed Salem et al.
CANCER RESEARCH (2018)
Inhibitory effect of icariin on osteosarcoma cell proliferation via the Wnt/-catenin signaling pathway
Yuxin Ren et al.
ONCOLOGY LETTERS (2018)
Anti-myeloma Effects of Icariin Are Mediated Through the Attenuation of JAK/STAT3-Dependent Signaling Cascade
Young Yun Jung et al.
FRONTIERS IN PHARMACOLOGY (2018)
First-in-human phase 1 study of the PARP/tankyrase inhibitor 2X-121 (E7449) as monotherapy in patients with advanced solid tumors and validation of a novel drug response predictor (DRP) mRNA biomarker.
Elizabeth Ruth Plummer et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
The putative tumour suppressor miR-1-3p modulates prostate cancer cell aggressiveness by repressing E2F5 and PFTK1
Sen-Mao Li et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
DBC1 regulates Wnt/β-catenin-mediated expression of MACC1, a key regulator of cancer progression, in colon cancer
Hwa Jin Kim et al.
CELL DEATH & DISEASE (2018)
MiR-1-3p inhibits cell proliferation and invasion by regulating BDNF-TrkB signaling pathway in bladder cancer
L. Gao et al.
NEOPLASMA (2018)
Icariin exerts inhibitory effects on the growth and metastasis of KYSE70 human esophageal carcinoma cells via PI3K/AKT and STAT3 pathways
Zhen-Fang Gu et al.
ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY (2017)
miR-216a inhibits osteosarcoma cell proliferation, invasion and metastasis by targeting CDK14
Quanbo Ji et al.
CELL DEATH & DISEASE (2017)
Regulation of Wnt/β-catenin signalling by tankyrase-dependent poly(ADP-ribosyl) ation and scaffolding
Laura Mariotti et al.
BRITISH JOURNAL OF PHARMACOLOGY (2017)
被撤回的出版物: MiR-1-3p Suppresses the Proliferation, Invasion and Migration of Bladder Cancer Cells by Up-Regulating SFRP1 Expression (Retracted article. See vol. 55, pg. 384, 2021)
Anquan Shang et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2017)
DDB2 Is a Novel Regulator of Wnt Signaling in Colon Cancer
Shuo Huang et al.
CANCER RESEARCH (2017)
WNT Signaling and Colorectal Cancer
Emma M. Schatoff et al.
CURRENT COLORECTAL CANCER REPORTS (2017)
Therapeutic Targeting of Tumor-Derived R-Spondin Attenuates β-Catenin Signaling and Tumorigenesis in Multiple Cancer Types
Cecile Chartier et al.
CANCER RESEARCH (2016)
Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974
Jonathan D. Boone et al.
LABORATORY INVESTIGATION (2016)
Sirolimus induces apoptosis and reverses multidrug resistance in human osteosarcoma cells in vitro via increasing microRNA-34b expression
Yan Zhou et al.
ACTA PHARMACOLOGICA SINICA (2016)
Anti-angiogenic agents in ovarian cancer: past, present, and future
B. J. Monk et al.
ANNALS OF ONCOLOGY (2016)
Wnt Signaling and Survival of Women With High-Grade Serous Ovarian Cancer A Brief Report
Brandon-Luke L. Seagle et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2016)
Overall survival in patients with platinum-sensitive recurrent serous ovarian cancer receiving olaparib maintenance monotherapy: an updated analysis from a randomised, placebo-controlled, double-blind, phase 2 trial
Jonathan A. Ledermann et al.
LANCET ONCOLOGY (2016)
Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its Derivatives
Hui-Li Tan et al.
FRONTIERS IN PHARMACOLOGY (2016)
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
Guoyan Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
miR-211 suppresses epithelial ovarian cancer proliferation and cell-cycle progression by targeting Cyclin D1 and CDK6
Bairong Xia et al.
MOLECULAR CANCER (2015)
Icariin regulates the proliferation and apoptosis of human ovarian cancer cells through microRNA-21 by targeting PTEN, RECK and Bcl-2
Jingwei Li et al.
ONCOLOGY REPORTS (2015)
Augmentation of Response to Chemotherapy by microRNA-506 Through Regulation of RAD51 in Serous Ovarian Cancers
Guoyan Liu et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
MicroRNA biogenesis pathways in cancer
Shuibin Lin et al.
NATURE REVIEWS CANCER (2015)
Icariin-Mediated Inhibition of NF-κB Activity Enhances the In Vitro and In Vivo Antitumour Effect of 5-Fluorouracil in Colorectal Cancer
De-Bing Shi et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2014)
Tankyrases: Structure, Function and Therapeutic Implications in Cancer
Teemu Haikarainen et al.
CURRENT PHARMACEUTICAL DESIGN (2014)
WNT/β-Catenin Signaling and Hepatocellular Carcinoma
Jack R. Wands et al.
HEPATOLOGY (2014)
MiR-506 suppresses proliferation and induces senescence by directly targeting the CDK4/6-FOXM1 axis in ovarian cancer
Guoyan Liu et al.
JOURNAL OF PATHOLOGY (2014)
Icariin potentiates the antitumor activity of gemcitabine in gallbladder cancer by suppressing NF-κB
Dian-cai Zhang et al.
ACTA PHARMACOLOGICA SINICA (2013)
The Wnt/β-catenin pathway in ovarian cancer: A review
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2013)
Therapeutic Synergy between microRNA and siRNA in Ovarian Cancer Treatment
Masato Nishimura et al.
CANCER DISCOVERY (2013)
MiR-182 overexpression in tumourigenesis of high-grade serous ovarian carcinoma
Zhaojian Liu et al.
JOURNAL OF PATHOLOGY (2012)
WNT7A Regulates Tumor Growth and Progression in Ovarian Cancer through the WNT/β-Catenin Pathway
Shin Yoshioka et al.
MOLECULAR CANCER RESEARCH (2012)
Growth Inhibition of Ovarian Tumor-Initiating Cells by Niclosamide
Yi-Te Yo et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Tankyrase-targeted therapeutics: expanding opportunities in the PARP family
Jenna L. Riffell et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
Renyue Bao et al.
PLOS ONE (2012)
Icariin exterts negative effects on human gastric cancer cell invasion and migration by vasodilator-stimulated phosphoprotein via Rac1 pathway
Yongping Wang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
MiR-15a and MiR-16 Control Bmi-1 Expression in Ovarian Cancer
Resham Bhattacharya et al.
CANCER RESEARCH (2009)
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
Bryan T. MacDonald et al.
DEVELOPMENTAL CELL (2009)
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Shih-Min A. Huang et al.
NATURE (2009)
Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2
Sun-Mi Park et al.
CELL CYCLE (2007)
Expression of cadherins and catenins correlates with distinct histologic types of ovarian carcinomas
David Sarrio et al.
HUMAN PATHOLOGY (2006)
Wnt-signalling pathway in ovarian epithelial tumours:: increased expression of β-catenin and GSK3β
K Rask et al.
BRITISH JOURNAL OF CANCER (2003)